Evaxion AS (EVAX)
3.36
+0.05
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
-0.15
(-4.46%)
After-Hours: 20:00
Evaxion Shareholders Equity (Quarterly) : 9.531M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.531M |
| March 31, 2026 | 13.21M |
| December 31, 2025 | 17.04M |
| September 30, 2025 | 16.60M |
| June 30, 2025 | 6.226M |
| March 31, 2025 | 10.34M |
| December 31, 2024 | -1.652M |
| September 30, 2024 | 0.074M |
| June 30, 2024 | 1.253M |
| March 31, 2024 | 2.604M |
| December 31, 2023 | -4.729M |
| September 30, 2023 | -2.734M |
| June 30, 2023 | 2.535M |
| March 31, 2023 | 6.575M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.303M |
| September 30, 2022 | 13.55M |
| June 30, 2022 | 20.15M |
| March 31, 2022 | 26.39M |
| December 31, 2021 | 32.44M |
| September 30, 2021 | 16.65M |
| June 30, 2021 | 21.83M |
| March 31, 2021 | 27.80M |
| December 31, 2020 | 7.038M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.362M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 74.84M |
| Cellectis SA | 41.07M |
| Akari Therapeutics Plc | 18.60M |
| DBV Technologies SA | -- |
| argenx SE | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.38M |
| Total Liabilities (Quarterly) | 9.849M |
| Debt to Equity Ratio | 0.7455 |
| Current Ratio | 5.062 |
| Net Debt Paydown Yield | -5.50% |